Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,809,814
-
Share change
-
+1,311,829
-
Total reported value
-
$101,969,985
-
Put/Call ratio
-
0.64%
-
Price per share
-
$4.90
-
Number of holders
-
49
-
Value change
-
+$6,420,332
-
Number of buys
-
29
-
Number of sells
-
11
Institutional Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q4 2016
As of 31 Dec 2016,
ARGOS THERAPEUTICS INC - COM (ARGS) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,809,814 shares.
The largest 10 holders included
Pharmstandard International S.A., WASATCH ADVISORS INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, BlackRock Fund Advisors, SANDERS MORRIS HARRIS INC., STATE STREET CORP, ALTRINSIC GLOBAL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.